WHO ICTRP trial
A randomized controlled, multicenter clinical study comparing the efficacy and…
ChiCTR2500108939 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500108939 |
|---|---|
| Public title | A randomized controlled, multicenter clinical study comparing the efficacy and safety of hydrocodone sustained-release tablets combined with denosumab in the treatment of solid tumor bone metastasis pain |
| Scientific title | A randomized controlled, multicenter clinical study comparing the efficacy and safety of hydrocodone sustained-release tablets combined with denosumab in the treatment of solid tumor bone metastasis pain |
| Primary sponsor | Fuzhou University Affiliated Provincial Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Cancer pain |
| Interventions | Hydromorphone Hydrochloride Sustained-release Tablets+denosumab:Hydromorphone Hydrochloride Sustained-release Tablets;Oxycodone sustained-release tablets+denosumab:Oxycodone sustained-release tablets |
| Registration date | Sep 9, 2025 |
| Target size | Hydromorphone Hydrochloride Sustained-release Tablets+denosumab:88;Oxycodone… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: